Trulieve Cannabis (TRLV) Accounts Payables (2020 - 2026)

Trulieve Cannabis has reported Accounts Payables for 7 years, with the latest figure at $61.5 million in Q2 2026.

• On a quarterly basis, Accounts Payables fell 22.2% year-over-year to $61.5 million in Q2 2026; TTM through Jun 2026 was $61.5 million, a 22.2% decrease from a year earlier, with the FY2025 full-year figure at $82.7 million, down 12.1% from the prior year.
• Accounts Payables was $61.5 million for Q2 2026 at Trulieve Cannabis, down from $78.9 million in the prior quarter.
• The five-year high for Accounts Payables was $109.8 million in Q1 2022, with the low at $61.5 million in Q2 2026.
• Average Accounts Payables over 5 years is $85.3 million, with a median of $83.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Accounts Payables surged 161.22% in 2022, then slipped 22.2% in 2026.
• Over 5 years, Accounts Payables stood at $82.0 million in 2022, then increased by 1.39% to $83.2 million in 2023, then advanced by 13.08% to $94.0 million in 2024, then dropped by 12.1% to $82.7 million in 2025, then decreased by 25.6% to $61.5 million in 2026.
• The last three Accounts Payables figures came in at $61.5 million (Q2 2026), $78.9 million (Q1 2026), and $82.7 million (Q4 2025), per Business Quant data.